GFI1B and small cell lung carcinoma: In our cell panel, we identified that all SCLC cell lines sensitive to GSK690 express SNAG domain proteins INSM1 or GFI1B; however, we also observed examples of INSM1 or GFI1B‐expressing cell lines that were also resistant to the drug (Fig. 2C).